van Bragt Stephanie, van den Bemt Lisette, Kievits Regien, Merkus Peter, van Weel Chris, Schermer Tjard
Department of Primary and Community Care , Radboudumc, Nijmegen , The Netherlands .
J Asthma. 2015 Mar;52(2):211-9. doi: 10.3109/02770903.2014.952439. Epub 2014 Aug 28.
Insufficient asthma management leads to impaired health-related quality of life (HRQL). The aim of this study is to assess whether individualized self-management (ISM) support will improve HRQL in children with asthma compared to enhanced usual care (EUC) in Dutch general practices.
A cluster-randomized controlled trial with 9-month follow-up. ISM is a nurse-led intervention that is optimized to the needs of children, leading to a written action plan. Power calculation demanded inclusion of 170 children (aged 6-11 years) diagnosed with asthma and active medication use.
Outcomes were HRQL of the child (Paediatric Asthma Quality of Life Questionnaire, PAQLQ-s) and several secondary outcomes. Data of 29 children (mean age 8.6 years, SD 1.7) were analyzed; ISM (n = 15) or EUC (n = 14). Logistic regression analysis (minimal clinical important difference; MCID ≥ 0.5) and descriptive analyses were performed. Despite high PAQLQ-s score at baseline (median ISM 6.35, EUC 6.02), a substantial number of subjects from both groups showed MCID of HRQL (ISM 33%, EUC 57%). Treatment differences on HRQL were not significant (OR 0.38, 95% CI 0.08, 1.69). Secondary outcomes did not show significant differences either, with exception of PAQLQ-s symptoms domain score in favor of EUC.
Due to recruitment problems and underpowered analyses, no firm conclusions on the effectiveness of ISM support for childhood asthma in primary care could be drawn. Still, this study can be considered a valuable pilot study and in the future, there might be better capacity in general practices to commit to such treatment.
哮喘管理不足会导致健康相关生活质量(HRQL)受损。本研究旨在评估与荷兰全科医疗中的强化常规护理(EUC)相比,个体化自我管理(ISM)支持是否能改善哮喘儿童的HRQL。
一项为期9个月随访的整群随机对照试验。ISM是一项由护士主导的干预措施,根据儿童需求进行优化,形成书面行动计划。样本量计算要求纳入170名6至11岁被诊断为哮喘且正在使用活性药物的儿童。
结局指标为儿童的HRQL(儿童哮喘生活质量问卷,PAQLQ-s)及若干次要结局指标。分析了29名儿童(平均年龄8.6岁,标准差1.7)的数据;其中ISM组(n = 15)和EUC组(n = 14)。进行了逻辑回归分析(最小临床重要差异;MCID≥0.5)和描述性分析。尽管两组在基线时PAQLQ-s评分较高(ISM组中位数为6.35,EUC组为6.02),但两组中仍有相当数量的受试者显示出HRQL的MCID(ISM组33%,EUC组57%)。两组在HRQL方面的治疗差异不显著(比值比0.38,95%置信区间0.08,1.69)。次要结局指标也未显示出显著差异,除了PAQLQ-s症状领域评分EUC组更优。
由于招募问题和分析效能不足,无法就ISM支持在基层医疗中治疗儿童哮喘的有效性得出确凿结论。尽管如此,本研究仍可被视为一项有价值的试点研究,未来全科医疗可能有更好的能力开展此类治疗。